305 results on '"Iversen, Lars"'
Search Results
2. The Epidemiology of Hospital-Treated Alopecia Areata in Denmark, 1995–2016
3. ERAP1 and ERAP2 Gene Variants as Potential Clinical Biomarkers of Anti-IL-17A Response in Psoriasis Vulgaris
4. Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome
5. Bimekizumab Versus Secukinumab Continuous Maintenance of PASI 90 and PASI 100 Responses through One Year in Patients with Moderate to Severe Plaque Psoriasis: Post-HOC Results from the BE RADIANT Phase 3b Trial
6. Rare coding variants in NOX4 link high ROS levels to psoriatic arthritis mutilans
7. Efficacy and Safety of the Heat Shock Protein 90 Inhibitor RGRN-305 in Hidradenitis Suppurativa
8. Effects on Local Oxygen Conditions by the Invasive Macrophyte Myriophyllum spicatum
9. Drivers and effects of construction-sand mining in Sub-Saharan Africa
10. Treatment or Psoriasis with Calcipotriene and Betamethasone Dipropionate (CAL/BDP) Cream Showed Significantly Higher Proportion of Patients with an Absolute mPASI≤2 Compared to CAL/BDP Gel/Topical Suspension in a Post-Hoc Aanalysis of Two Phase 3 Studies
11. Investigation of plaque psoriasis relapse after secukinumab withdrawal in patients from two Phase 3 studies
12. Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative Review
13. PsoBarrier EU study: a Multicentre, Cross-sectional Survey Investigating the Quality of Psoriasis Care in Four European Countries
14. Chronic Obstructive Pulmonary Disease and Risk of Cutaneous T-cell Lymphoma: A Danish Population-based Cohort Study
15. Mettre l’Afrique sur la carte
16. Putting Africa on the map
17. Lyme neuroborreliosis presenting with urinary retention and spastic paraparesis
18. Treatment Preferences in Young Adults with Moderate to Severe Psoriasis: A Qualitative Study from the Nordic Countries
19. Rare coding variants inNOX4link high superoxide levels to psoriatic arthritis mutilans
20. Single-Centre Real-World Study on Drug Survival and Effectiveness of Brodalumab for Treatment of Psoriasis and Psoriatic Arthritis
21. Religiøse trender i Norge og Religion i medienes grepPål RepstadReligiøse trender i NorgeOslo, Universitetsforlaget, 2020. 164 sider. ISBN 9788215046259Knut LundbyReligion i medienes grep.Oslo, Universitetsforlaget, 2021. 272 sider. ISBN 9788215047607
22. Prioritizing taxa for genetic reference database development to advance inland water conservation
23. Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis—a randomized controlled trial (PSORRO)
24. Single-Particle Tracking of Thermomyces lanuginosus Lipase Reveals How Mutations in the Lid Region Remodel Its Diffusion
25. Sensory properties analysis of a calcipotriol and betamethasone dipropionate cream vehicle formulated with an innovative PAD Technology for the treatment of plaque psoriasis on the skin and scalp
26. Predicting and controlling ecological communities via trait and environment mediated parameterizations of dynamical models
27. Arthritis Hit Rate in Patients with Psoriasis Referred for Rheumatology Evaluation
28. Phase 3 Trial Demonstrating High Efficacy, Favourable Safety, and Convenience of a Novel Calcipotriene and Betamethasone Dipropionate Cream
29. Endolysin Inhibits Skin Colonization by Patient-Derived Staphylococcus Aureus and Malignant T-Cell Activation in Cutaneous T-Cell Lymphoma
30. Activation and inhibition of the C-terminal kinase domain of p90 ribosomal S6 kinases
31. Heat shock protein 90 inhibitor RGRN-305 potently attenuates skin inflammation
32. Innledning
33. Secukinumab demonstrates superiority over narrow‐band ultraviolet B phototherapy in new‐onset moderate to severe plaque psoriasis patients: Week 52 results from the STEPIn study
34. Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma
35. Global change and plant-ecosystem functioning in freshwaters
36. Guselkumab, tildrakizumab, and risankizumab in a real-world setting: drug survival and effectiveness in the treatment of psoriasis and psoriatic arthritis
37. miRNA Signature in Early-stage Mycosis Fungoides
38. Real-World Effectiveness and Safety of SDZ-ADL (Adalimumab Biosimilar) in Patients with Psoriasis from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR)
39. Global circRNA expression changes predate clinical and histological improvements of psoriasis patients upon secukinumab treatment
40. Early intervention and disease memory in psoriasis: A literature review
41. ESDR365 - Secukinumab normalizes skin transcriptomes to a never-lesional state in new-onset psoriasis patients more rapidly than in chronic patients
42. ESDR056 - Highly Multiplexed Digital Spatial Profiling of Resolved Psoriasis Skin From Dead Sea Climatotherapy or Secukinumab Treated Patients
43. ESDR354 - Heat Shock Protein 90 Inhibitor Attenuates Inflammation Induced by 12-O-tetradecanoylphorbol-13-acetate in Primary Human Keratinocytes and Mice
44. 33884 Complete skin clearance for patients with moderate to severe plaque psoriasis: The relationship between improvements in Psoriasis Area and Severity Index and health-related quality of life
45. Circulating Brodalumab Levels and Therapy Outcomes in Patients With Psoriasis Treated With Brodalumab
46. Comorbidity in Adult Psoriasis: Considerations for the Clinician
47. Quantification of Immunohistochemically Stained Cells in Skin Biopsies
48. Climatotherapy at the Dead Sea for psoriasis is a highly effective anti‐inflammatory treatment in the short term: An immunohistochemical study
49. Activation and inhibition of the C-terminal kinase domain of p90 ribosomal S6 kinases
50. Towards linking freshwater plants and ecosystems via functional biogeography
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.